Introduction
Injectable hydrogels are of continued and growing interest in a variety of biomedical settings, from delivery of cancer therapeutics to applications in regenerative medicine. Hydrogels with high loading capacity can locally deliver bioactive cargoes (e.g., proteins and cells) with varying degrees of tunable release www.advancedsciencenews.com www.advhealthmat. de for the delivery of small bioactive proteins. [6] For example, for intracellular delivery, Zhong and co-workers established hyaluronic acid nanogels that degrade in response to reducing microenvironments through disulfide bonds and subsequently release cytochrome C and granzyme B for the treatment of lung carcinoma. [7] For extracellular delivery, Burdick and co-workers demonstrated that injectable polysaccharide-based hydrogels that degrade in response to matrix metalloproteinases (MMPs) could be utilized to release a tissue inhibitor of MMPs to modulate cellular activity during the wound healing cascade following myocardial infarction. [8] Building upon these advances, we hypothesized that noncovalent protein-polysaccharide interactions in conjunction with controlled hydrogel degradation in response to endogenous and exogenous stimuli would afford precise control over the release kinetics of low molecular weight proteins, such as growth factors and cytokines, ranging from a few days to weeks in vitro and in vivo.
In the work presented herein, we demonstrate the design, synthesis, and application of an injectable hydrogel-based material for the responsive and tailorable release of small bioactive proteins with broad applicability toward the in situ modulation of biological processes in regenerative medicine and disease treatment. To enable hydrogel formation as well as degradation in response to endogenous stimuli, we incorporated an arylthiol-based crosslinker to form succinimide thioether linkages that are susceptible to thiol exchange reactions in glutathione (GSH)-rich reducing microenvironments, such as those found within carcinoma tissue. In addition, to enable degradation that can be tailored with exogenous stimuli, we synthesized a new o-nitrobenzyl (o-NB) aryl-thiol moiety that is responsive to externally applied, cytocompatible doses of light. Both macromers were designed free of ester bonds to mitigate material degradation by hydrolysis and allow precise and responsive control of degradation reactions and hydrogel dissolution. For the retention of small bioactive proteins, such as basic fibroblast growth factor (FGF-2), interleukin-2 (IL-2), or vascular endothelial growth factor (VEGF), heparin crosslinks were incorporated to promote electrostatic protein-polysaccharide binding. The rate and extent of hydrogel degradation with different stimuli and degradable content were characterized using oscillatory rheometry. These handles for modulation of hydrogel degradation subsequently were utilized to control the release of a model bioactive protein FGF-2 (≈17.2 kDa), which is a potent mitogen that plays an important role in cell proliferation, migration, and wound healing. [9] Stimuli-responsive release of FGF-2 was investigated in vitro and in vivo, and retention of protein bioactivity was verified. This material system and approach can easily be applied for local, tailored delivery of other low molecular weight proteins with heparin affinity, such as IL-2 for melanoma treatment or VEGF for regenerative medicine applications.
Results and Discussion

Material Design and Synthesis
Hydrogels based on poly(ethylene glycol) (PEG) are well suited for drug delivery applications owing to their excellent biocompatibility, their tunable mechanical properties, and the ease of control over their chemical modification. [5, 10] The release of cargo from PEG-based hydrogels generally is controlled by Fickian diffusion (e.g., encapsulation of protein and release by passive or hindered diffusion), material degradation (e.g., entrapment of protein and release upon crosslink cleavage), or a combination of both. The incorporation of natural polymers (e.g., polysaccharides such as heparin) within hydrogels allows for noncovalent interactions with biological cargo, which both improve the stability of cargo molecules during the encapsulation process and the control of cargo release kinetics. [11] The heterogeneity of the glycosaminoglycan heparin, coupled with its highest negative charge density among naturally occurring polymers, facilitates ionic interactions with a wide variety of proteins, growth factors, and cytokines. [12] Hence, we hypothesized that a hydrogel incorporating different endogenous and exogenous stimuli-responsive moieties and heparin would afford control over the release of low molecular weight protein cargo by a combination of heparin-mediated interactions and degradation-mediated changes in mesh size (Figure 1) .
We aimed to design building blocks for the formation of water-stable hydrogels that are degradable exclusively by responsive mechanisms using amide linkages rather than esters, owing to their long-term stability in aqueous microenvironments. Building upon our prior success with aryl-thiolbased thioether succinimide linkages for GSH-responsive release, [13, 14] we conjugated aryl-thiol groups to amine-endfunctionalized PEG (PEG-4-NH 2 ) using carbodiimide chemistry ( Figure 1B ). Direct addition of mercaptophenylacetic acid (MPA) to PEG-4-NH 2 was challenging due to the formation of thioester linkages (i.e., reaction of the sulfhydryl groups with the carboxylic acids), which are unstable under aqueous conditions. Hence, MPA was first oxidized using hydrogen peroxide (H 2 O 2 ) in the presence of sodium iodide (NaI) as a catalyst to form disulfide bonds that prevent the participation of sulfhydryl groups in subsequent reactions with activated carboxylic acids. The carboxylic acid groups on the oxidized MPA were activated with 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo [4,5-b] pyridinium 3-oxid hexafluorophosphate (HATU) in the presence of N,N-diisopropylethylamine (DIPEA) to form an amide linkage with PEG-4-NH 2 . Successively, the polymer was reduced in the presence of tris(2-carboxyethyl)phosphine (TCEP) to generate reactive sulfhydryl groups in acidic conditions (pH ≈4). The reaction yielded aryl-thiol end-functionalized polymers with 88% modification as assessed by the integration of aromatic protons within the 1 H NMR spectrum ( Figure S1 , Supporting Information).
To enable exogenously triggered, light-mediated degradation of the hydrogels, an o-NB moiety was incorporated within PEG-4-MPA ( Figure 1B) . The o-NB moiety undergoes irreversible photo isomerization in response to externally applied cytocompatible doses of light. [15] In our previous work, we incorporated an ester-linked maleimide o-NB moiety onto a four-arm PEG macromer; [13] however, this formulation presented challenges due to hydrolysis of the maleimide ring during monomer synthesis in addition to the rapid hydrolysis (k = 6.84 × 10 −4 min −1 ) of esters within the resulting hydrogels in aqueous solution. To address these issues, a new amide-linked MPA o-NB was synthesized on PEG-4-NH 2 (Scheme S1, Supporting Information).
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Amine end-functionalized PEG (I) was reacted with the carboxylic acid of Fmoc-protected o-NB groups (II) using carbodiimide chemistry. Subsequently, the Fmoc protecting group on the photodegradable PEG (III) was cleaved in the presence of piperidine to generate an amine end-functionalized photodegradable PEG intermediate (IV). Intermediate IV was reacted with oxidized MPA in a similar manner as described earlier to obtain aryl-thiol end-functionalized photodegradable PEG (PEG-4-PD-MPA) with 78% modification, as indicated by 1 H NMR ( Figure S3 , Supporting Information). To the best of our knowledge, this is the first reported synthesis of an aryl-thiol end-functionalized photodegradable PEG macromer for controlling hydrogel degradation.
To enable the retention of small proteins with affinity binding, heparin was functionalized with maleimide groups for incorporation as crosslinks within the responsive hydrogels ( Figure 1C ). Heparin-and heparin-sulfate-based polymers have been utilized in a variety of hydrogels for controlling the release of proteins with receptor-ligand interactions. [16] The large electronegative charge of heparin [12] facilitates its role in multivalent binding of many proteins, including FGF-2 (k d = 0.47 × 10 −6 m), [17] IL-2 (k d = 0.5 × 10 −6 m), [18] and VEGF (k d = 0.52 × 10 −6 m). [19] Here, the carboxylic acid groups on uronic acid residues of heparin were functionalized with maleimide groups using a heterofunctional N-(2-aminoethyl) maleimide trifuoroacetate salt (AEM) and carbodiimide coupling chemistry (Scheme S2, Supporting Information). Optimization of the reactant stoichiometry for the carbodiimide reaction yielded maleimide end-functionalized heparin with Adv. Healthcare Mater. 2017, 6, 1700713 Figure 1 . Polymeric building blocks for hydrogel formation. A) Reducing-microenvironment-or light-sensitive hydrogels were formed by reacting B) an aryl-thiol end-functionalized poly(ethylene glycol) macromolecular precursor (PEG-4-MPA) or a photodegradable aryl-thiol end-functionalized PEG (PEG-4-PD-MPA) with a maleimide-end-functionalized PEG (PEG-2-MI) and a maleimide-functionalized low molecular heparin (Heparin-MI) via a Michael-type reaction in an aqueous microenvironment. Low molecular weight proteins, such as growth factors (FGF-2 in the present study), cytokines, and immunomodulatory agents, can be incorporated within the hydrogel during network formation utilizing heparin-associated receptor-ligand interactions for protein retention. C) Aryl-thiol-based succinimide thioether linkages exchange with free thiols in solution, leading to the formation of a relatively stable alkyl-thiol (i.e., cysteine)-based succinimide thioether linkage, resulting in hydrogel degradation. D) The photolabile o-nitrobenzyl moieties undergo irreversible photoisomerization in response to cytocompatible doses of long wavelength UV or visible light, yielding ketone and amide products.
www.advancedsciencenews.com www.advhealthmat.de a functionality of 2.2, as characterized by integration of the protons from the maleimide ring compared to the anomeric protons of heparin in 1 H NMR spectroscopy ( Figure S2 , Supporting Information), providing sufficient functionality for the modified heparin to act as a crosslinker. Hydrogels with the thiol-and light-responsive PEG-4-PD-MPA and electrostatic heparin building blocks, respectively, were formed using a Michael-type addition reaction between the sulfhydryl groups of PEG-4-PD-MPA and the maleimide groups of PEG-2-MI and heparin-MI. The Michael-type addition reaction is a versatile and robust click reaction that occurs readily in aqueous conditions at room temperature. [20] In addition, the reaction does not generate any byproducts, and hence, it has been used widely to design cytocompatible hydrogels. [21] We hypothesized that the rapid chemical crosslinking afforded by this reaction would allow the in situ formation of hydrogels upon injection of liquid-gel forming precursors and the encapsulation of bioactive proteins for degradation-mediated release.
In chemically crosslinked hydrogels, the crosslinking reaction plays a crucial role in hydrogel formation and their resulting mechanical properties. In particular, for injectable hydrogels, liquid precursor solutions need to be rapidly polymerized at the site of interest to avoid uncontrolled diffusion of polymers and cargo molecules into the surrounding tissues. Dynamic time sweep experiments were conducted to study hydrogel formation and gelation kinetics. The storage (G′) and loss moduli (G″) were recorded for a 7.5 wt% hydrogel composition using a parallel plate geometry, where time sweep measurements were taken within the linear viscoelastic regime (1% strain, 6 rad s −1 angular frequency). As indicated in Figure S4 (Supporting Information), the storage modulus rapidly increased within the initial ≈2 min from 16 to ≈2000 Pa, while no significant change was observed in the loss modulus, indicating the formation of a hydrogel. The crossover point between G′ and G″ was not observed before the first data point was acquired, suggesting rapid hydrogel gelation and the potential utility of this material for local injection.
Completion of gelation was achieved after the plateau region was reached, where no significant change in G′ was observed between measurements. Postformation, the storage modulus was significantly higher than the loss modulus as measured by frequency sweeps (0.1-100 rad s −1 ) ( Figure S4 , Supporting Information), demonstrating the elastic nature of the network. The modulus observed for these materials is comparable to that of thiol-maleimide hydrogel formulations with lower polymer concentrations (i.e., 5 wt%, G′ ≈ 2300 Pa). [14] This disparity can be attributed to additional network defects, such as looping or unreacted functional groups, that may be associated with the incorporation of heparin-MI, which significantly impact the crosslink density and ultimately the mechanical properties of the resulting hydrogels. [22] Regardless, our results indicate reproducible and robust hydrogel formation using this Michaeltype addition reaction with a gelation time under 30 s.
Hydrogels Degrade in Response to Endogenous and Exogenous Stimuli
We first investigated the degradation of hydrogels formed with water-stable, aryl-thiol-based succinimide thioether linkages, which can undergo a retro-Michael addition in reducing environments, enabling protein release in response to endogenous stimuli. Under nonreducing conditions, the reaction between the aryl-thiol and the maleimide yields a succinimide thioether linkage with the reaction equilibrium directed toward the product. Under reducing conditions, during the reverse reaction, an exogenous thiol, such as that presented by GSH, can react with the maleimide to form a relatively stable alkyl-thiolbased succinimide thioether linkage, which is dependent on the pK a of both the aryl-thiol and the exogenous thiol. The formation of a relatively stable alkyl-thiol-based succinimide thioether bond results in the breakage of the original hydrogel crosslink, ultimately leading to network degradation.
After characterizing the modulus of the hydrogel under steady state conditions (e.g., at equilibrium in aqueous solution), we next sought to establish the effect of glutathione concentration on the rate of hydrogel degradation to understand the limits of material responsiveness to an endogenous stimulus. In the human body, the concentration of glutathione varies significantly from the micromolar to the millimolar range; [23] in particular, in tumors, the concentration of thiols varies from 1 × 10 −3 to 1.5 × 10 −3 m.
[23] Hence, we studied the effects of 0, 1 × 10 −3 , and 10 × 10 −3 m GSH on the rate of hydrogel degradation. To study hydrogel degradation, we monitored the mechanical properties of hydrogels as a function of time using oscillatory rheometry to assess any decrease in the storage modulus over time that would indicate a decrease in the crosslink density of the hydrogel. The storage modulus at each time point was measured, and the degradation rate was obtained by fitting a plot of the normalized storage modulus as a function of time to first-order degradation kinetics (Figure 2A) . Here, the rate of degradation is proportional to the number of degradable linkages owing to the excess concentration of GSH relative to succinimide thioether linkages. At a concentration of 10 × 10 −3 m GSH, the degradation rate constant was found to be 1.46 × 10 −3 min −1 (t 1/2 = 474 min), with complete erosion, or reverse gelation, occurring after 48 h (2 d). At the lower glutathione concentration (1 × 10 −3 m GSH), the degradation rate constant was found to be 4.47 × 10 −4 min −1 (t 1/2 = 1550 min), with complete erosion occurring after 168 h (7 d). Hydrogels incubated in phosphate buffered saline (PBS) buffer containing no GSH (i.e., 0 m GSH) were found to be stable during the experimental time frame (>7 d). Since the glutathione concentration varies significantly in vivo, the responsiveness to different glutathione concentrations offers a promising approach to specifically deliver cargo molecules at varied rates for particular sites of interest.
As many therapeutics require doses over different time scales, ranging from a few days to weeks, the ability to easily tune the rate of hydrogel degradation and related therapeutic release profiles is crucial for broad applicability. To simply tune the rate of degradation of the current hydrogels using retroMichael and thiol exchange reactions, we varied the percent of degradable crosslinks within the hydrogel. Previous studies have demonstrated that alkyl-thiol-based succinimide thioether linkages are stable in reducing microenvironments. [14] Hence, the ratio of alkyl-thiol and aryl-thiol within the precursor solution was varied to obtain hydrogels with 33%, 66%, or 100% degradable linkages. Varying the ratio of alkyl-to aryl-thiols www.advancedsciencenews.com www.advhealthmat.de (i.e., stable to GSH-responsive thiols) did not affect the final storage modulus postformation, indicating that similar crosslinking density was achieved irrespective of the chemical identity of the thiol functional groups. Hydrogels subsequently were incubated in PBS buffer containing 10 × 10 −3 m GSH at room temperature, and the storage modulus was measured at predefined time points. The rate of degradation was calculated by plotting the normalized storage modulus as a function time.
As is apparent in Figure 2B , all conditions showed a decrease in the storage modulus, indicating hydrogel degradation in the reducing microenvironment. As noted earlier, the 100% degradable hydrogels showed rapid degradation in a reducing microenvironment with a rate constant of 1.46 × 10 −3 min −1 and complete erosion occurring after 48 h (2 d). Hydrogels containing 66% degradable groups exhibited a relatively slower rate of degradation (k = 6.49 × 10 −4 min −1 ), where complete erosion was observed after 96 h (4 d). The hydrogels containing 33% degradable groups exhibited the slowest degradation among these three conditions, with a degradation rate constant of 3.59 × 10 −4 min −1
. These hydrogels did not undergo complete erosion, as this four-arm PEG network contained fewer than 50% degradable crosslinks, but were too soft to handle and measure mechanically after 120 h (5 d). These results demonstrate a facile method for controlling degradation kinetics by varying the percentage of degradable crosslinks within the hydrogel.
Although these materials allow GSH-responsive degradation, hydrogel-based drug carriers that degrade in response to multiple triggers, including exogenous stimuli such as externally applied light, would allow spatial and temporal control over drug release for applications in precision medicine. [24] In the present work, incorporation of an o-NB moiety into the hydrogel backbone added another handle to control not only the rate of hydrogel degradation, but also the time at which degradation was induced. The effect of externally applied light on the photodegradation of PEG-heparin hydrogels was investigated using cytocompatible doses of long wavelength UV and visible light. In our previous studies, hydrogel degradation was achieved using externally applied light; however, the incorporation of ester bonds caused rapid and uncontrolled ester hydrolysis. [13] The presence of esters in that hydrogel system, consequently, presented significant challenges for future applications in drug delivery, where long-term release (days to weeks) is needed. Hence, we sought to replace the labile ester linkages within the macromers with amide linkages. While the replacement of ester linkages with amide linkages improved the stability of the hydrogel in an aqueous microenvironment, the rate of photodegradation was 2.5 times slower as compared to our previous study (k photodegradation, amide = 0.12 min A) The rate of hydrogel degradation was found to be responsive to glutathione (GSH) concentration. In a high reducing microenvironment (10 × 10 −3 m), like that found intracellularly, the rate of degradation was an order of magnitude faster when compared to a lower reducing microenvironment (1 × 10 −3 m) like that within carcinoma tissues, indicating the promise of this approach for reducing-microenvironment-sensitive therapeutic release. The degradation half-lives of hydrogels exposed to different concentrations of GSH were found to be 474 and 1550 min for high and low concentrations of GSH, respectively. B) Using different ratios of alkyl-to aryl-thiols, the number of degradable crosslinks was varied between 33% and 100%, which in turn controlled the rate of bulk hydrogel degradation. The degradation half-life was found to be ≈2550 and 635 min for 66% and 100% degradable hydrogels, respectively; the 33% degradable hydrogel, as expected, did not undergo complete degradation. C) Photodegradable MPA-based hydrogels undergo degradation in response to externally applied light (10 mW cm −2 at 365 nm). The rate of photodegradation was evaluated in the linear region between 6 and 16 min, yielding a rate constant of 0.12 min −1 for photocleavage and degradation half-life of ≈8.3 min for hydrogels irradiated with low intensity, long wavelength UV light. The data shown illustrate the mean (n ≥ 3) with error bars showing the standard error.
www.advancedsciencenews.com www.advhealthmat.de rates; however, the rate of degradation did not decrease as much as previously reported when using an amide linkage. [25, 26] For example, Anseth and co-workers demonstrated ≈15% degradation of an amide-linked photodegradable hydrogel in ≈6 min using a tenfold higher light intensity (102 mW cm −2 ) than was needed to degrade an ester-linked photodegradable hydrogel network. [25] We hypothesize that the electron-withdrawing nature of the aryl-thiol substituent contributed to the faster degradation rate than typically observed for other amide linked o-NB groups.
Dually Responsive Hydrogels Allow Controlled Release of a Model Small Bioactive Protein FGF-2 In Vitro
Growth factor release profiles are of interest in the present work, given our ultimate interest in the controlled delivery of low molecular weight therapeutic proteins. To this end, the release of FGF-2 from PEG-heparin hydrogels was investigated in vitro. FGF-2 (≈17.2 kDa) is a mitogenic protein that plays a key role in various cellular processes, including cell proliferation, cell migration, wound healing, and endocrine signaling pathways. [9] FGF-2 also has a comparable molecular weight and heparin-binding affinity to that of the immune-activating cytokine IL-2 that is commonly used for the treatment of melanoma by intralesional injection, as outlined in the National Comprehensive Cancer Network guidelines. [17, 18, 27] Both proteins are rapidly degraded in solution, and a controlled drug delivery carrier that retains bioactivity while enabling controlled release in vivo could increase its therapeutic efficacy. [28] In the present studies, FGF-2 loaded hydrogels were incubated in reducing and nonreducing aqueous microenvironments (i.e., PBS buffer containing 10 × 10 −3 m GSH and 0 m GSH, respectively), and aliquots were removed at predetermined time points over the course of one week. The concentration of the released FGF-2 subsequently was determined using an enzyme-linked immunosorbent assay (ELISA). The cumulative FGF-2 release was calculated as a function of time as shown in Figure 3A . Under nonreducing conditions, FGF-2 loaded hydrogels exhibited a slight burst release, with ≈20% of the total FGF-2 released during the experimental time frame. This initial release of FGF-2 can be attributed to passive diffusion of FGF-2 out of the hydrogel, partly driven by the large concentration gradient of FGF-2 between the hydrogel and the sink solution. Notably, under reducing conditions, ≈40% of the total FGF-2 was released over 3 d, upon which complete erosion of the hydrogel occurred. The continued release of FGF-2 from the hydrogel after the reverse gel point is hypothesized to be continued dissociation of FGF-2 from the heparin monomers after the hydrogel is degraded for a total release of ≈90% of loaded FGF-2. The difference in the FGF-2 release profiles for hydrogels in reducing and nonreducing conditions clearly demonstrates that the release of low molecular weight proteins can be tuned by controlling hydrogel degradation. In addition, the electrostatic heparin-protein interaction prevents free diffusion of FGF-2 from the hydrogels after the initial burst release (hydrodynamic radius of FGF-2 = 2.8 nm, [29] estimated mesh size ≈8 nm). Indeed, Kizilel and co-workers reported rapid release of bovine serum albumin (BSA, hydrodynamic radius = 3.56 nm) and glucagon-like peptide (GLP-1, hydrodynamic radius = 1.3 nm) from similar PEG hydrogels. [30] Approximately 80% of the loaded BSA was released within 3000 min, whereas GLP-1 was released within 300 min, highlighting the importance of heparin-mediated electrostatic interactions for the sustained release of small proteins from PEG-based hydrogels. Light-mediated hydrogel degradation and subsequent release of FGF-2 were studied to demonstrate the release of FGF-2 over a shorter time period in response to externally applied cytocompatible doses of light (10 mW cm −2 at 365 nm). The amount of FGF-2 released from hydrogels was quantified using an ELISA assay. Pristine FGF-2 in solution did not exhibit any significant changes in concentration, as measured via ELISA, when exposed to externally applied UV light ( Figure S5 Release of FGF-2 in response to a reducing microenvironment was monitored in vitro using an enzyme-linked immunosorbent assay (ELISA) (reducing microenvironment: PBS buffer containing 10 × 10 −3 m GSH; control: nonreducing microenvironment PBS buffer). Hydrogels exhibit minimal burst release in the nonreducing microenvironment. In contrast, under the reducing microenvironment, FGF-2 was released rapidly, with ≈40% of cargo released before complete erosion (i.e., reverse gelation, noted with arrow at 4300 min), and ≈80-95% was released upon complete hydrogel degradation. Upon hydrogel dissolution at 4300 min, the amount of FGF-2 released under the reducing microenvironment was statistically significant compared to FGF-2 released under the nonreducing microenvironment. B) Release of FGF-2 in response to cytocompatible, clinically relevant light doses (10 mW cm −2 at 365 nm) was monitored using an ELISA. A statistically significant increase in FGF-2 release was observed with irradiation times sufficient for light-mediated erosion of the surface of the hydrogel in comparison to the control (no light). The data shown illustrate the mean (n ≥ 4) with error bars showing the standard error. * indicates p < 0.05, ** indicates p < 0.01. www.advancedsciencenews.com www.advhealthmat.de light applied. A significant difference in the release profile was observed when hydrogels were irradiated compared to a no light control ( Figure 3B ). Negligible FGF-2 release was observed during the first 20 min of irradiation, consistent with the degradation kinetics of the aryl-thiol-based, amide-linked photolabile group as well as the ELISA detection limit. After the reverse gel point was reached for the top layer of the hydrogel (≈30 min for this surface eroding, optically thick hydrogel), continued release of FGF-2 was observed as it dissociates from the free heparin monomers over time. Overall, these results indicate that cargo release can be tuned by application of cytocompatible doses of light.
Released Protein Retains Bioactivity
FGF-2 is known to promote proliferation of many cell types, including primary human aortic adventitial fibroblasts (AF). [31] Thus, we set out to determine the bioactivity of FGF-2 after encapsulation and release from hydrogels following well-established protocols, [32] specifically examining the effect of released components on AF proliferation. Hydrogels containing FGF-2 were suspended in reducing and nonreducing microenvironments at 4 °C (to minimize protein degradation); after 7 d, the supernatant was lyophilized and reconstituted at a concentration of 1 ng mL −1 FGF-2 in stromal cell basal medium (SCBM) containing 5% stripped serum. After 48 h of culture, AFs were treated with 10 × 10 −6 m 5-ethynyl-2-deoxyuridine (EdU) for an additional 24 h. AFs cultured in SCBM containing 1 ng mL −1 fresh pristine FGF-2 were utilized as a positive control, whereas AF cultures in the absence of FGF-2 served as a negative control. Cell proliferation was quantified by examining the number of EdU-positive AFs after 72 h of culture ( Figure 4A ). AFs treated with released FGF-2 exhibited a proliferation rate of 27%, which was similar to the proliferation rate observed for AFs treated with pristine FGF-2 ( Figure 4B ). These results indicate that bioactive FGF-2 can be liberated upon stimulation of FGF-2-containing depots.
Hydrogel Degradation Mediates Release of FGF-2 In Vivo
Hydrogel degradation and protein release in vivo was subsequently investigated within healthy tissue in mice, which should represent roughly the slowest GSH-responsive release achievable with this system. Specifically, hydrogel precursors were subcutaneously injected for in situ hydrogel formation, and the diameter of the resulting hydrogel was monitored over approximately two months. Hydrogels that contained thiolsensitive linkages showed a decrease in hydrogel diameter, with complete degradation observed by day 25 (i.e., no detectable hydrogel upon palpitation) ( Figure 5A ). Hydrogels containing alkyl-thiol-based succinimide thioether linkages served as a nondegradable control and were stable over the experiment time course (up to 60 d). The slower rate of degradation of the thiol-sensitive hydrogels in vivo, in comparison to the rate observed in vitro (Figure 2A ), likely can be attributed to a lower concentration of GSH within healthy tissues than that probed in the in vitro experiments. FGF-2 labeled with Alexa Fluor 647 (AF-647) was encapsulated within hydrogels during hydrogel formation and its release was tracked over time with fluorescence imaging to evaluate if protein release could be controlled in vivo with the degradation of the hydrogel depot. Mice with in situ formed hydrogels containing AF-647-labeled FGF-2 were imaged at predetermined time points to monitor the release of FGF-2 from the hydrogel into the surrounding tissue. The total fluorescence intensity within the hydrogel was divided by the area of the hydrogel, and then normalized to the day 0 measurement, for each hydrogel condition. The release of FGF-2 was observed to be more rapid from thiol-sensitive hydrogels (aryl-thiol-based linkages) than nondegradable hydrogels (alkyl-thiol-based linkages) ( Figure 5B) . Notably, FGF-2 release was observed to be concatenate with the degradation of the hydrogel in the degradable formulation, whereas its release from the nondegradable formulation over four weeks is controlled strictly by affinity interactions. Differences in total fluorescence within the Figure 4 . Bioactivity of released FGF-2. A) Bioactivity of FGF-2 that was released from PEG-heparin hydrogels was studied in vitro using an adventitial fibroblast (AF) proliferation assay, as FGF-2 is known to promote cell proliferation. FGF-2 that was released from the hydrogels was added to AFs during in vitro cell culture, and proliferating cell nuclei were labeled with Alexa Fluor 555 (red) using an EdU assay (scale bar, 200 µm). B) Released FGF-2 demonstrated a similar effect on cell proliferation as pristine FGF-2 added at a similar concentration (positive control) relative to cells in growth medium alone (negative control), indicating that the protein bioactivity was not affected during the encapsulation and subsequent release process. Data shown illustrate the mean (n ≥ 4) with error bars showing the standard error. * indicates p < 0.05.
www.advancedsciencenews.com www.advhealthmat.de hydrogels are observed at one week, supporting degradationmediated release of FGF-2. At longer times, release of FGF-2 from the nondegradable hydrogels is not unexpected, given that the FGF-2 should dissociate from heparin over time by affinitymediated release into the surrounding microenvironment. The relatively faster release of cargo from the degradable hydrogels compared to the nondegradable hydrogels is similar to the trend observed in the in vitro experiments. The radial fluorescence profiles of the hydrogels were also investigated to further understand the release of AF-647-labeled FGF-2 from the different hydrogel compositions ( Figure 5C ,E, representative images Figure 5D,F) . In the nondegradable hydrogels, we observed a nonsignificant increase in fluorescence from day 1 to day 6 associated with the inherent variability in the experiment. From day 6 to day 26, the normalized fluorescence intensity decreased from 1.31 to 0.13 at the center of hydrogels, which can be attributed to FGF-2 dissociation from heparin and subsequent diffusion into the surrounding microenvironment. [33] For the 100% degradable hydrogels, a rapid decrease in the normalized fluorescence intensity from 1.00 to 0.12 was observed between day 0 to day 6. This release of protein correlates with the timeframe of hydrogel degradation ( Figure 5A ). In conjunction with our in vitro observations ( Figure 3A) , these results indicate that protein release Adv. Healthcare Mater. 2017, 6, 1700713 Figure 5 . In vivo hydrogel degradation. A) The ability of hydrogels to degrade in vivo was monitored in a mouse model. After subcutaneous injection, the hydrogel diameter was measured with calibers to monitor the change in the size of the hydrogels over a 60 d time course. At 25 d, no hydrogel was detectable upon palpitation for the 100% degradable hydrogels, whereas little change in size was observed for the nondegradable control hydrogel. B) The fluorescence of injected hydrogels containing fluorescently labeled FGF-2 was monitored for 26 d post injection. The total fluorescence was divided by the area of the hydrogel and subsequently normalized to the average fluorescence on day 0. The radial distribution of FGF-2 from C) nondegradable (open markers) and E) degradable hydrogels (closed markers) was determined to monitor FGF-2 release from the hydrogel network. Representative images of these hydrogels are shown for day 1 and day 26 for D) nondegradable and F) degradable hydrogel formulations. Taken together, FGF-2 release was observed to be concatenate with the degradation of the hydrogel for the degradable formulation, whereas its release was controlled strictly by affinity interactions for the nondegradable formulation over four weeks. Data shown illustrate the mean (n ≥ 3) with error bars showing the standard error.
www.advancedsciencenews.com www.advhealthmat.de likely was driven by both passive and hindered diffusion from the hydrogel upon initial burst and subsequent degradationmediated mesh size changes, respectively. The normalized intensity value was similar from day 6 to day 26 (from 0.12 to 0.13, respectively), indicating that most of the loaded protein is released within the first week for the degradable hydrogel condition. Overall, protein release was controlled at short periods (approximately one to two weeks) with hydrogel degradation, and at long periods (one month), complete release of FGF-2 was achieved with either hydrogel formulation. Importantly, the 100% degradable hydrogel composition was completely eroded, providing a mechanism for clearance from the body without surgical removal of the depot.
Conclusion
We report the synthesis of water-stable, stimuli-responsive hydrogels in which degradation can be tailored by varying the degradable chemistries that are responsive to reducing microenvironments and externally applied cytocompatible doses of light. Hydrogels were formed rapidly using facile Michael-type reactions and exhibited controlled degradation in the presence of biologically relevant reducing microenvironments (e.g., 1 × 10 −3 -10 × 10 −3 m GSH) via retro-Michael and subsequent exchange reactions. The rate of hydrogel degradation was found to be dependent on the content of degradable crosslinks and to be responsive to the strength of the reducing microenvironment. Incorporation of an o-NB moiety allowed light-triggered hydrogel degradation. Protein release (FGF-2) was controlled by hydrogel degradation by both endogenous and exogenous stimulus in vitro (over days to minutes, respectively), up until the reverse gel point. The bioactivity of released FGF-2 was comparable to pristine FGF-2, indicating the ability of the hydrogel to retain the bioactivity of cargo molecules during encapsulation and release. Further, successful hydrogel degradation and FGF-2 release was observed in vivo in a murine model. This hydrogel-based, responsive depot is promising for the controlled delivery of FGF-2 in a number of biomedical applications, such as cardiovascular tissue engineering and vascular graft surgeries: release profiles that are sustained (in healthy tissues), responsive (in GSH-enriched tissues), or pulsatile (upon application of light) can be achieved to drive a variety of cellular processes when and where needed. [34] The presented approach could also be easily translated for the release of other heparin-binding proteins of comparable molecular weight and heparin binding affinity, such as the immune activating cytokine IL-2. [17, 18] In summary, the results of our study indicate that incorporation of receptor-host interactions along with chemistries that respond to endogenous and exogenous stimuli can be utilized to control the release of low molecular weight proteins.
Experimental Section
Materials: General organic reagents and solvents were purchased from commercial sources and used as received. Four-arm aminefunctionalized poly(ethylene glycol) (PEG-4-NH 2 , M n ≈ 10 000 g mol ) and linear maleimide-functionalized poly(ethylene glycol) (PEG-MI, M n ≈ 5000 g mol −1 ) were purchased from JenKem Technology USA Inc. (Allen, TX). 4-[4-[1-(9-Fluorenylmethyloxycarbonylamino)ethyl]-2-methoxy-5-nitrophenoxy]butanoic acid (Fmoc-PD) was purchased from Advanced ChemTech (Louisville, KY). Deionized water (18 MΩ cm) was used for experimental procedures. All reactions were conducted in glassware that was oven-dried and cooled while purging with argon. All reactions were performed in duplicate under an inert argon atmosphere using a Schlenk line unless noted otherwise.
Synthesis of Aryl-Thiol End-Functionalized PEG: Sulfhydryl groups on MPA were oxidized using hydrogen peroxide in the presence of sodium iodide based on previously published protocol. [35] Briefly, 0.5 g (3 mmol) of MPA was dissolved in 10 mL of ethyl acetate (EtOAc) in the presence of NaI (4.4 mg, 0.03 mmol) and 30% hydrogen peroxide solution (H 2 O 2 , 95 mg, 3 mmol, Scheme S3, Supporting Information). The solution was stirred at room temperature for 3 h without inert gas atmosphere. Saturated sodium thiosulfate (Na 2 S 2 O 3 ) was subsequently added to the reaction mixture (10 mL), and the resulting solution was extracted with EtOAc. The organic phase was isolated and subsequently concentrated by rotary evaporation, and was further purified using silica gel column chromatography (1:1 hexane:EtOAc).
Purified oxidized MPA (100 mg, 0.6 mmol), HATU (228 mg, 0.6 mmol), and DIPEA (130 mg, 1 mmol) were dissolved in dimethylformamide (DMF) (20 mL), and amine-end-functionalized PEG (500 mg, 0.05 mmol) was subsequently added and reacted overnight at room temperature. The reaction solution was precipitated in ethyl ether (10× excess) at 4 °C. The precipitated polymer product was separated using centrifugation, and dried polymer was obtained by removal of residual solvents under reduced pressure at room temperature. The polymer was subsequently reduced overnight in the presence of TCEP (470 mg, 1.64 mmol) stirred in deionized (DI) water (20 mL) at room temperature. The reaction mixture was dialyzed (molecular weight cut-off (MWCO) 2000 Da) against 3.5 liters of acidic DI water (pH ≈4 adjusted using hydrochloric acid) with a total of three changes over 24 h at room temperature and then lyophilized to obtain a pale white solid. The degree of thiol functionalization was determined with 1 H NMR spectroscopy (δ 7.19-7.13 ppm, Figure S1 , Supporting Information) using a Bruker AVIII 600 NMR spectrometer (Bruker Daltonics, Billerica, MA) with deuterated dimethyl sulfoxide (DMSO) as the solvent.
Synthesis of Maleimide-Functionalized Heparin: Low molecular weight heparin was modified with maleimide groups based on previously published protocols. [36] Briefly, 980 mg (0.22 mmol) of heparin (Lovenox, average molecular weight ≈4500 g mol −1 ) was dissolved in 100 mL of 0.1 m 2-(N-morpholino)ethanesulfonic acid buffer (pH = 6.0). Subsequently, 246 mg (1.46 mmol) of 1-hydroxybenzotriazole hydrate, 246 mg of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (1.28 mmol), and 246 mg (0.96 mmol) of AEM were dissolved and reacted overnight at room temperature under inert atmosphere. The product was subsequently purified using dialysis (MWCO 1000 Da) against 1 m NaCl and deionized water with a total of three changes over 48 h. The reaction mixture was subsequently lyophilized to yield a solid white product. Degree of functionalization (f = 2.2) was determined using maleimide protons in downfield region (δ 6.83 ppm, Figure S2 , Supporting Information) using 1 H NMR with deuterated H 2 O as the solvent.
Synthesis of Aryl-Thiol End-Functionalized Photodegradable PEG: Fmoc-PD (200 mg, 0.4 mmol), HATU (152 mg, 0.40 mmol), and DIPEA (104 mg, 0.8 mmol) were dissolved in DMF (10 mL), and amine-endfunctionalized PEG (500 mg, 1 mmol) was added to the reaction. The reaction solution was stirred overnight at room temperature and subsequently precipitated in ice cold ethyl ether (100 mL). Solid polymer was obtained by filtration and subsequent solvent removal at reduced pressure. The Fmoc group was subsequently removed by dissolving the solid polymer in DMF (30 mL) containing 20% v/v piperidine. The reaction solution was stirred overnight at room temperature; the product was isolated by precipitation (ice cold ethyl ether); and any residual solvent was removed as described earlier. The polymer endfunctionalized with the photolabile precursor subsequently was reacted www.advancedsciencenews.com www.advhealthmat.de with oxidized MPA and purified as described earlier (final purification of aryl-thiol end-functionalized PEG: precipitation, filtration, drying, dialysis, and lyophilization) to obtain aryl-thiol end-functionalized photodegradable PEG. The degree of functionalization was determined with 1 H NMR spectroscopy (δ 7.18-7.11 ppm, Figure S3 , Supporting Information) with deuterated DMSO as the solvent. Hydrogel Formation and Rheological Characterization: Thiolfunctionalized monomers were dissolved in citric acid buffer (pH = 3 prepared using citric acid and disodium phosphate), and maleimidefunctionalized monomers were dissolved in phosphate buffered saline (pH = 7). Maleimide-functionalized heparin was mixed with PEG-MI such that 15% of the MI functional groups were contributed by the heparin-maleimide. Thiol-functionalized and maleimide-functionalized monomers were subsequently mixed at 4 °C with a 1:1 thiol:maleimide molar ratio to form 7.5 wt% (w/w) hydrogels. For rheological studies, the hydrogels were formed directly on the rheometer (AR-G2, TA Instruments, USA). Mixed precursor solutions were added directly onto a Peltier plate without any apparent increase in the solution viscosity and a 20 mm parallel plate geometry was lowered immediately (120 µm gap). Time sweep measurements were carried out within the linear viscoelastic regime (1% constant strain mode at a frequency of 6 rad s −1 ) at 25 °C. Three independent samples per hydrogel composition were analyzed.
Hydrogel Degradation: For hydrogel degradation studies, hydrogels were formed by mixing 7.5 wt% precursor solutions in a cylindrical mold (diameter = 4.6 mm, thickness = 1.8 mm, volume = 30 µL; e.g., 1 mL syringe with the end cut off) at a stoichiometry of 1:1 thiol:maleimide. The solutions were allowed to gel overnight to ensure maximum possible crosslinking. Resulting hydrogels were washed with PBS (2 mL) and incubated in a reducing microenvironment (1 × 10 −3 or 10 × 10 −3 m GSH dissolved in PBS refrigerated until use) at room temperature over the experimental time frame. At predefined time points, the mechanical properties of the hydrogels were assessed using oscillatory rheometry (2 rad s −1 , 2% strain, 0.25 N force to avoid hydrogel slip) within the linear viscoelastic regime. For light-mediated degradation studies, hydrogels were formed directly on the quartz plate of a UV light accessory (TA Instruments) with a small stoichiometric excess of maleimide (thiol:maleimide ratio = 1:1.1) to avoid any unreacted thiol functional groups. After complete gelation, samples were irradiated with a low dose of long wavelength UV light (10 mW cm −2 at 365 nm; Exfo Omnicure Series 2000 light source with 365 nm bandpass filter, SilverLine UV or International Light Radiometer). Storage and loss moduli were simultaneously measured with a 20 mm parallel plate geometry using dynamic time sweep measurements under the linear viscoelastic regime (6 rad s −1 , 1% strain). Six independent samples per time point were analyzed.
FGF-2 Release: For growth factor release studies, polymer precursor solutions were mixed along with FGF-2 at a loading concentration of 1 ng µL −1 and subsequently pipetted into a cylindrical mold (diameter = 4.6 mm, thickness = 1.8 mm, volume = 30 µL; e.g., 1 mL syringe with end cut off). The solutions were allowed to gel at 4 °C for 8 h. Hydrogel disks were washed with PBS thrice to remove any surface-bound FGF-2 and subsequently incubated in 10 × 10 −3 m glutathione in PBS buffer (2 mL volume). The samples were gently shaken on a shaker plate, and 100 µL of sink solution was removed at predetermined time points and replaced with 100 µL of fresh GSH in PBS. The amount of released FGF-2 was quantified using an ELISA assay (Peprotech, Rocky Hill, NJ). The cumulative release at each time point was calculated using following equation 
where V m and V r indicate the amount of sink solution used for the release measurement and the remaining volume of the sink solution at each time point, respectively (i.e., total volume of the sink, V = V r + V m ); C is the concentration of released FGF-2 obtained using an ELISA assay and the appropriate calibration curve; and i is the number of experimental time points. Four samples per time point were analyzed.
